Background Hypoglycemia and renal dysfunction are common in diabetes and may reflect high-risk cardiometabolic vulnerability during heart failure hospitalization. Objective To evaluate whether early hypoglycemia and severe renal dysfunction jointly predict 30-day death or heart failure readmission among patients with diabetes hospitalized for heart failure. Methods We performed a retrospective cohort study using MIMIC-IV v3.1. Adults with diabetes and a first qualifying heart failure hospitalization were included if glucose and creatinine data were available within 24 hours of admission. Hypoglycemia was defined as any glucose <70 mg/dL, and severe renal dysfunction as creatinine ≥2.0 mg/dL. Patients were categorized as having neither marker, hypoglycemia alone, severe renal dysfunction alone, or both. The primary outcome was all-cause death or heart failure readmission within 30 days. Logistic regression adjusted for age and sex. Results Among 12,515 patients, 542 (4.3%) had hypoglycemia, 2,993 (23.9%) had severe renal dysfunction, and 216 (1.7%) had both. The overall 30-day event rate was 24.4%. Event rates were 22.4% with neither marker, 27.3% with hypoglycemia alone, 29.6% with severe renal dysfunction alone, and 38.4% with both. Compared with neither marker, severe renal dysfunction alone (odds ratio [OR] 1.50, 95% confidence interval [CI] 1.36-1.65) and concurrent hypoglycemia plus severe renal dysfunction (OR 2.25, 95% CI 1.70-2.98) were associated with higher early risk. Conclusions In patients with diabetes hospitalized for heart failure, early hypoglycemia combined with severe renal dysfunction identified a high-risk cardiorenal-metabolic phenotype. Integrating glucose and renal markers may improve discharge risk stratification. Is this an encore abstract? No
No takes yet. Share an insight, caveat, or question.
Moseley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: